$31.5
Currently 31 wall-street analysts regularly analyze the financials of Genmab A/s on a frequent basis to provide recommendations along with target share price. 31 analysts offering 12-month price forecasts for Genmab A/s (GMAB) have a share price target of $37.81. This median of share price forecast represents a 20.05% upside from the latest price of $31.5 as on 20.12.25.
As per the chart shown above, analysts believe that the Genmab A/s (GMAB) share price will touch around $37.81 in next 12-months.
Below is a chart showing the percentage difference between Genmab A/s's share price and its median forecast price. As on 20.12.25, the difference is -16.99%
Based on 31 analysts tracking and researching Genmab A/s (GMAB) share have buy recommendation on an average.
| 3M Ago | 1M Ago | Current | |
| Buy | 14 | 13 | 13 |
| Outperform | 6 | 6 | 6 |
| Hold | 9 | 9 | 9 |
| Underperform | 1 | 1 | 2 |
| Sell | 3 | 2 | 1 |